In United StatesLupin
announced the launch of its Memantine Hydrochloride Extended-Release Capsules, 7mg, 14mg, 21mg, 28mg having received an approval from the United States
Food and Drug Administration (FDA) earlier.
Lupin's Memantine Hydrochloride ER capsules 7mg, 14mg, 21mg, 28mg are the generic equivalents of Allergan's Namenda XR1' capsules. It is indicated for the treatment of moderate to severe dementia of the
Memantine Hydrochloride ER capsules 7mg, 14mg, 21mg, 28mg had annual sales of approximately USD 936 million in the US (IQVIA MAT December 2017).
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)